New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

Medications like semaglutide and liraglutide may help to reduce the risk of heart attacks, strokes, and other major adverse ...

Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

Kelly Clarkson discussed her weight loss journey during a performance, revealing a disagreement with her talk show's HR about ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals ... a similar study published in 2021 reported a 14.9% loss with semaglutide after 68 weeks. The benefit of this ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

New study finds weight loss jabs not only help tackle obesity but may significantly reduce alcohol use, offering wide health ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...